Hepatitis E virus (HEV) is an enterically transmitted virus that primarily infects hepatocytes and causes hepatitis E, an acute inflammatory liver disease. Although often self-limiting, HEV infection can become severe in specific populations, particularly pregnant individuals and those with pre-existing liver disease. The virus is a major cause of waterborne hepatitis globally and represents an important emerging infectious disease in both low-resource and high-income settings.

HEV was long considered a disease of developing regions, associated with poor sanitation and contaminated drinking water. However, it is now recognized as a globally distributed pathogen with multiple transmission routes, including zoonotic and foodborne pathways. This broader epidemiological understanding has reshaped how hepatitis E is studied in virology and public health.

From a biological perspective, hepatitis E virus is an RNA virus with distinctive structural and genetic features that place it in the family Hepeviridae. Its ability to infect both humans and animals, combined with its environmental stability and diverse transmission routes, makes it a complex and increasingly important pathogen.

HEV infection is generally acute and self-limiting, but its clinical impact can be severe in vulnerable populations. In pregnant individuals, particularly in the third trimester, mortality rates can be significantly elevated. This unique pathogenic profile distinguishes hepatitis E from other hepatitis viruses and underscores its importance in global health surveillance.

Biological Characteristics of Hepatitis E Virus

Hepatitis E virus belongs to the family Hepeviridae and is classified within the genus Paslahepevirus for mammalian-infecting strains. It is a non-enveloped or quasi-enveloped, positive-sense single-stranded RNA virus.

Virion Structure and Genome Organization

HEV virions are approximately 27–34 nanometers in diameter. In fecal–oral transmission, the virus exists as a non-enveloped particle, while in blood circulation it can appear in a quasi-enveloped form cloaked in host-derived membranes. This dual state contributes to immune evasion and differing stability characteristics in various environments.

The viral genome is approximately 7.2 kilobases in length and contains a 5′ cap and a 3′ poly(A) tail. It encodes three major open reading frames (ORF1, ORF2, and ORF3), with a potential additional ORF4 identified in some genotypes.

ORF1 encodes a large nonstructural polyprotein that includes functional domains such as RNA helicase, methyltransferase, and RNA-dependent RNA polymerase. ORF2 encodes the capsid protein responsible for virion assembly and host immune recognition. ORF3 encodes a small multifunctional phosphoprotein involved in viral egress and modulation of host cell signaling.

Genotypes and Host Range

HEV is genetically diverse and classified into several genotypes. Genotypes 1 and 2 are primarily restricted to humans and are associated with large waterborne outbreaks in developing regions. Genotypes 3 and 4 are zoonotic and infect both humans and animals such as pigs, deer, and wild boar.

This zoonotic capability is a key feature distinguishing HEV from many other hepatitis viruses and contributes to foodborne transmission in industrialized countries.

Environmental Stability

HEV is relatively stable in the environment, especially in its non-enveloped form found in feces. It can persist in water sources and resist moderate environmental stress, enabling transmission through contaminated drinking water and food supplies.

In contrast, quasi-enveloped HEV circulating in blood is more sensitive to immune detection but less stable outside the host. This duality reflects adaptation to both systemic infection and fecal shedding.

Entry into Host Cells and Viral Replication

Hepatitis E virus exhibits hepatotropism, preferentially infecting liver cells. Viral entry and replication involve interactions between viral capsid proteins and host cell factors that are still being actively studied.

Attachment and Entry

HEV entry into hepatocytes begins with attachment of the capsid protein (ORF2 product) to host cell surface molecules, including heparan sulfate proteoglycans and other putative receptors.

The virus is internalized through clathrin-mediated endocytosis. Acidification of endosomes facilitates uncoating and release of viral RNA into the cytoplasm.

Translation of Viral Genome

Once in the cytoplasm, the positive-sense RNA genome functions directly as messenger RNA. Host ribosomes translate ORF1 into a multifunctional nonstructural polyprotein.

This polyprotein contains enzymatic domains required for viral RNA synthesis, including RNA-dependent RNA polymerase, which is essential for replication of the viral genome.

RNA Replication

Viral replication occurs in cytoplasmic complexes associated with modified intracellular membranes. The RNA-dependent RNA polymerase synthesizes a complementary negative-sense RNA intermediate, which serves as a template for production of new genomic RNA.

Subgenomic RNA is also produced and used for translation of ORF2 and ORF3 proteins, ensuring coordinated production of structural components and assembly factors.

Assembly and Release

Newly synthesized capsid proteins encapsidate genomic RNA to form progeny virions. Assembly occurs in the cytoplasm, followed by release through cellular pathways involving ORF3-mediated budding processes.

In blood, HEV may acquire a host-derived lipid envelope during egress, which helps evade neutralizing antibodies. In feces, this envelope is lost, resulting in highly stable, environmentally resistant virions.

Transmission and Epidemiology

Hepatitis E virus is transmitted through multiple routes depending on genotype and geographic region. The primary route is fecal–oral transmission via contaminated water.

Waterborne Transmission

Genotypes 1 and 2 are responsible for large waterborne outbreaks in regions with inadequate sanitation. Contamination of drinking water sources with human feces is the main driver of these epidemics.

Such outbreaks are often associated with heavy rainfall, flooding, or breakdowns in water treatment infrastructure.

Zoonotic and Foodborne Transmission

Genotypes 3 and 4 are zoonotic and transmitted from animals to humans, primarily through consumption of undercooked pork, wild game, or contaminated meat products.

Pigs are the most important reservoir species. HEV infection in swine is typically asymptomatic, facilitating silent circulation in agricultural settings.

Bloodborne Transmission

HEV can also be transmitted via blood transfusion, organ transplantation, and, less commonly, vertical transmission from mother to child.

Bloodborne transmission is more relevant in high-income countries where zoonotic and transfusion-associated cases predominate rather than waterborne outbreaks.

Global Distribution

Hepatitis E is globally distributed but shows distinct regional patterns. High-incidence waterborne outbreaks occur in parts of Asia, Africa, and the Middle East, while sporadic zoonotic cases are more common in Europe and North America.

Differences in sanitation infrastructure, dietary habits, and animal husbandry practices strongly influence regional epidemiology.

Pathogenesis and Effects on Human Health

HEV infection primarily targets the liver, leading to acute hepatitis characterized by hepatocellular inflammation and immune-mediated injury.

Acute Hepatitis E

The incubation period typically ranges from 2 to 8 weeks. Early symptoms include fever, fatigue, anorexia, nausea, vomiting, and abdominal discomfort, followed by jaundice and dark urine in many cases.

In most immunocompetent individuals, infection is self-limiting and resolves within several weeks without chronic sequelae.

Immune-Mediated Liver Injury

Liver damage in HEV infection is primarily immune-mediated rather than directly cytopathic. CD8-positive T cells and inflammatory cytokines contribute to hepatocyte injury during viral clearance.

The severity of disease reflects a balance between viral replication and host immune response.

Severe Disease in Pregnancy

One of the most important clinical features of hepatitis E is its severity in pregnant individuals, particularly in the third trimester.

In this group, mortality rates can be significantly elevated, with increased risk of fulminant hepatic failure. The exact mechanisms remain unclear but may involve hormonal, immunological, and viral factors.

Chronic Infection in Immunocompromised Hosts

Although HEV is typically acute, chronic infection can occur in immunocompromised individuals, such as organ transplant recipients or patients receiving immunosuppressive therapy.

Chronic HEV infection can lead to progressive liver fibrosis and cirrhosis if untreated, particularly with genotype 3 infections.

Extrahepatic Manifestations

HEV infection has been associated with neurological complications such as Guillain-Barré syndrome, neuralgic amyotrophy, and encephalitis, suggesting systemic immune involvement beyond the liver.

Immune Response and Immune Evasion

The immune response to HEV involves both innate and adaptive components, although viral strategies for immune modulation are still being elucidated.

Innate Immunity

Innate immune responses include interferon production and activation of antiviral signaling pathways. HEV proteins can modulate these pathways to enhance viral survival during early infection.

Adaptive Immunity

Neutralizing antibodies against the ORF2 capsid protein play a central role in viral clearance and protection from reinfection.

T-cell responses also contribute to clearance of infected hepatocytes and resolution of infection.

Immune Evasion

The quasi-enveloped form of HEV in blood helps shield viral particles from neutralizing antibodies, while non-enveloped fecal forms are optimized for environmental stability rather than immune evasion.

Diagnosis and Laboratory Detection

Diagnosis of hepatitis E relies on serological and molecular methods.

Serological Testing

Detection of anti-HEV IgM antibodies indicates recent infection, while IgG antibodies suggest past exposure or immunity.

Molecular Testing

Reverse transcription PCR is used to detect HEV RNA in blood or stool, confirming active infection and allowing genotype determination.

Treatment and Clinical Management

Most cases of hepatitis E are self-limiting and require only supportive care, including hydration and symptom management.

Management of Severe and Chronic Cases

In chronic infections, particularly in immunocompromised patients, reduction of immunosuppressive therapy may promote viral clearance.

Antiviral therapy with ribavirin has shown effectiveness in treating chronic HEV infection in some cases.

Vaccination and Prevention

A recombinant HEV vaccine has been developed and licensed in some countries, demonstrating high efficacy in preventing symptomatic infection.

However, global use remains limited, and prevention strategies continue to rely heavily on sanitation, safe drinking water, and food safety practices.

Public Health Measures

Improving water quality, sewage disposal systems, and hygiene practices are essential for controlling waterborne outbreaks.

Food safety measures, including proper cooking of pork and game meat, are important for reducing zoonotic transmission.

Public Health Importance

Hepatitis E virus is a significant global public health concern due to its epidemic potential, severe outcomes in vulnerable populations, and diverse transmission routes.

Outbreak Potential

Large waterborne outbreaks can affect thousands of individuals, particularly in regions with inadequate sanitation infrastructure.

Burden in Vulnerable Populations

Pregnant individuals and immunocompromised patients experience disproportionately severe disease, contributing to preventable morbidity and mortality.

Emerging Zoonotic Threat

Increasing recognition of zoonotic transmission highlights the importance of food safety and animal reservoir management in industrialized countries.

Research Directions and Future Challenges

Research into HEV focuses on improving understanding of viral replication, host interactions, and mechanisms underlying severe disease in pregnancy.

Additional priorities include expanding vaccine availability, developing antiviral therapies for chronic infection, and improving surveillance of zoonotic transmission.

Understanding genotype-specific differences in pathogenicity and transmission will be essential for refining public health interventions.

Conclusion

Hepatitis E virus is a genetically diverse RNA virus that causes acute hepatitis through fecal–oral, zoonotic, and bloodborne transmission routes. Its unique biology, including quasi-enveloped circulation and environmental stability, enables efficient spread in both developing and developed regions.

While most infections are self-limiting, HEV can cause severe disease in pregnant individuals and chronic infection in immunocompromised hosts, making it a pathogen of significant clinical importance.

Continued improvements in sanitation, food safety, vaccination, and antiviral therapy are essential for reducing the global burden of hepatitis E and addressing its evolving public health challenges.